CORALAB

Coral Laboratories financials

Market cap
₹163 Cr

Quarterly results

Q1 FY27: revenue up 57.4%, net profit up 110.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue32 23 28 19 19 −41%22 −6%26 −6%30 +57%
EBITDA7 6 3 2 5 −24%2 −70%6 +130%5 +152%
Net profit6 6 3 3 6 −9%3 −55%5 +84%5 +111%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +12.1% 1Y

₹400₹500₹600Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹521.8 on 10 Sept 2025 → ₹585. High ₹665.15 (19 Aug 2026), low ₹362.05 (27 Mar 2026).

Financials, as filed

Revenue grew 1.3% a year over 2 years, FY24 to FY26. Operating margin narrowed to 17.7%.

Year endingFY24FY25FY26
Revenue₹84 Cr₹115 Cr₹86 Cr
Operating profit₹16 Cr₹26 Cr₹15 Cr
Operating margin19.4%22.8%17.7%
Interest₹0 Cr₹0 Cr₹0 Cr
Depreciation₹2 Cr₹2 Cr₹2 Cr
Net profit₹16 Cr₹24 Cr₹16 Cr
Net margin18.9%21.0%19.1%
Cash from operations₹-5 Cr₹-1 Cr₹16 Cr
Free cash flow₹-6 Cr₹-4 Cr₹-5 Cr
ROCE13.0%17.0%11.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
Reserves₹133 Cr₹152 Cr₹151 Cr₹174 Cr₹210 Cr₹206 Cr
Borrowings₹6 Cr₹6 Cr₹0 Cr₹0 Cr₹1 Cr₹4 Cr
Other liabilities₹25 Cr₹28 Cr₹20 Cr₹28 Cr₹19 Cr₹27 Cr
Total liabilities₹168 Cr₹190 Cr₹174 Cr₹206 Cr₹233 Cr₹241 Cr
Fixed assets₹21 Cr₹24 Cr₹25 Cr₹24 Cr₹24 Cr₹44 Cr
Capital work in progress₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹14 Cr₹0 Cr
Investments₹33 Cr₹46 Cr₹41 Cr₹50 Cr₹57 Cr₹46 Cr
Other assets₹112 Cr₹118 Cr₹108 Cr₹132 Cr₹138 Cr₹150 Cr
Total assets₹168 Cr₹190 Cr₹174 Cr₹206 Cr₹233 Cr₹241 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

The ownership split has held steady since Jun 2025. The shareholder count shrank 8% to 3,873.

Promoters
71.5%
Public
28.5%

Since Jun 2025

  • Public −0.01 pp
  • Promoters 0.00 pp
  • FIIs 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 71.5%, FIIs 0.1%, Public 28.3%.Dec '23: Promoters 71.5%, FIIs 0.1%, Public 28.4%.Mar '24: Promoters 71.5%, FIIs 0.1%, Public 28.4%.Jun '24: Promoters 71.5%, FIIs 0.2%, Public 28.3%.Sep '24: Promoters 71.5%, Public 28.5%.Dec '24: Promoters 71.5%, Public 28.5%.Mar '25: Promoters 71.5%, Public 28.5%.Jun '25: Promoters 71.5%, Public 28.5%.Sep '25: Promoters 71.5%, Public 28.5%.Dec '25: Promoters 71.5%, Public 28.5%.Mar '26: Promoters 71.5%, Public 28.5%.Jun '26: Promoters 71.5%, Public 28.5%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Coral Laboratories Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Chetan Navinchandra Doshi 51.54%unchanged
Coral India Finance and Housing Limited 19.97%unchanged
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs 2.64%newly disclosed
Meeta Samir Sheth 1.84%unchanged
Pooja Bhagwandas 1.83%unchanged
Neelam Mittal 1.14%unchanged
Noetic Finance Private Limited 1.06%unchanged
Manav Chetan Doshi 0.00%newly disclosed
Meera Chetan Doshi 0.00%newly disclosed
Kundan Navinchandra Doshi 0.00%unchanged
Navinchandra Bachubhai Doshi 0.00%unchanged
Iepf off the list

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.